An Interaction Effect Analysis of Thermodilution-Guided Hemodynamic Optimization, Patient Condition, and Mortality after Successful Cardiopulmonary Resuscitation.
Enikő KovácsValéria Anna GyarmathyDavid PileckyAlexandra Fekete-GyőrZsófia Szakál-TóthLászló GellérBalázs HauserJános GálBéla MerkelyEndre ZimaPublished in: International journal of environmental research and public health (2021)
Proper hemodynamic management is necessary among post-cardiac arrest patients to improve survival. We aimed to investigate the effects of PiCCO™-guided (pulse index contour cardiac output) hemodynamic management on mortality in post-resuscitation therapy. In this longitudinal analysis of 63 comatose patients after successful cardiopulmonary resuscitation cooled to 32-34 °C, 33 patients received PiCCO™, and 30 were not monitored with PiCCO™. Primary and secondary outcomes were 30 day and 1 year mortality. Kaplan-Meier curves and log-rank tests were used to assess differences in mortality among the groups. Interaction effects to disentangle the relationship between patient's condition, PiCCO™ application, and mortality were assessed by means of Chi-square tests and logistic regression models. A 30 day mortality was significantly higher among PiCCO™ patients, while 1 year mortality was marginally higher. More severe patient condition per se was not the cause of higher mortality rate in the PiCCO™ group. Patients in better health conditions (without ST-elevation myocardial infarction, without cardiogenic shock, without intra-aortic balloon pump device, or without stroke in prior history) had worse outcomes with PiCCO™-guided therapy. Catecholamine administration worsened both 30 day and 1 year mortality among all patients. Our analysis showed that there was a complex interaction relationship between PiCCO™-guided therapy, patients' condition, and 30 day mortality for most conditions.
Keyphrases
- cardiac arrest
- end stage renal disease
- cardiopulmonary resuscitation
- newly diagnosed
- ejection fraction
- chronic kidney disease
- prognostic factors
- stem cells
- heart failure
- risk factors
- cardiovascular disease
- atrial fibrillation
- mesenchymal stem cells
- metabolic syndrome
- public health
- mental health
- percutaneous coronary intervention
- coronary artery
- blood brain barrier
- risk assessment
- brain injury
- cross sectional
- adipose tissue
- climate change
- patient reported outcomes
- smoking cessation
- cell therapy
- insulin resistance
- pulmonary arterial hypertension